F. Bolognani et al., In vitro and in vivo herpetic vector-mediated gene transfer in the pituitary gland: impact on hormone secretion, EUR J ENDOC, 145(4), 2001, pp. 497-503
Objective: Herpes simplex virus type 1 (HSV-1)-derived vectors are known to
be effective tools to deliver transgenes into normal and neoplastic anteri
or pituitary (AP) cells in vitro. Our objective was to assess the in vitro
and in vivo effects of tsK/beta -gal, a temperature-sensitive HSV-1-derived
vector harbouring the E. coli beta -galactosidase gene, on AP hormone secr
etion as well as on transgene expression in rat AP tumours (hyperplastic pr
olactinomas).
Design: The impact of vector infection on prolactin (PRL) and GH release wa
s determined in vitro in normal and hyperplastic (lactotrophic) dispersed A
P cells exposed for 24 h to tsK/beta -gal as well as in vivo in ectopic AP
grafts. In some oestrogen-induced prolactinoma-carrying rats, vector suspen
sion was stereotaxically injected into the glands to assess transgene expre
ssion in vivo.
Methods: GH and PRL release was measured by specific RIAs. In vivo transgen
e expression was assessed by immunohistochemistry for beta -galactosidase a
nd enzymohistochemistry (5-bromo-4-chloro-3-indolyl-beta -D-galactopyranosi
de). Ectopic pituitary grafts and stereotaxic surgery were performed follow
ing standard procedures.
Results: At a multiplicity of infection of 0.5, the vector induced a 30 and
22% fall in PRL and GH release respectively in normal AP cells, whereas th
e corresponding hormone release inhibition for hyperplastic AP cells was 41
and 33% for PRL and GH respectively. In ectopic pituitary grafts, the effe
ct of vector infection on hormone secretion was assessed by measuring serum
PRL levels in the host rats every 5 days for 4 weeks post-grafting. In the
pituitary-grafted rats that received the viral vector, serum PRL failed to
increase to the levels achieved in control-grafted animals. Finally, pitui
tary tumours stereotaxically injected with tsK/beta -gal showed widespread
expression of the beta -galactosidase transgene around the injection areas.
Conclusions: The results reported here have implications for basic studies
using gene transfer to pituitary gland as well as potential gene therapy ap
proaches to pituitary diseases.